Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD

Inclusion Criteria

• •Patient can be included in the study only once.
• •1. Age \> 18 years.
• •2. Patient receiving lipid-lowering therapy with statin monotherapy or statins in combination with ezetimibe for both primary and secondary prevention of CVD.
• •3. Receiving statins as monotherapy or statins in combination with ezetimibe in a stable dosing regimen for 3 or more months at the time of enrolment in the study.
• •4. Willingness and ability to sign an informed consent to participate in the study.
• •5. Availability of primary medical documentation, which allows assessment of all parameters necessary for the study from the moment of initiation of statin monotherapy or statins in combination with ezetimibe.
• •6. Initiation of lipid-lowering therapy not earlier than 2 years before enrolment into the study.